StockData
Pulmonx Corp logo

Pulmonx Corp (LUNG) stock

LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/3044% below fair value
$2.73−0.06 (-2.32%)

Close on Nov 17, 2026Market cap $117.46MP/E –Yield –

Pulmonx price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Pulmonx's price to book ratio was 3.3× on Nov 11, 2026, against 1.1× a year earlier. Over the last 5 years it ranged from 1.0× to 5.8×, with a median of 2.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.3×+1.7
2025Dec 31, 20251.5×−1.3
2024Dec 31, 20242.9×−1.0
2023Dec 29, 20233.9×+2.0
2022Dec 30, 20221.9×−3.9
2021Dec 31, 20215.8×–

More Pulmonx figures

See a number that looks wrong?